东方生物：拟终止研发项目，剩余募资补流待股东会审议

Core Viewpoint - The company announced the termination of the "Technology Research and Development Center Construction Project" and plans to permanently supplement remaining raised funds and interest into working capital for daily operations [1] Group 1: Project Termination - The project was initially planned with an investment of 82.572 million yuan, of which 49.4616 million yuan has been invested as of December 23, leaving 42.318 million yuan unutilized [1] - The termination is attributed to the impact of public health events, leading the company to use its own funds for research equipment and building construction, resulting in no current need for significant further investment in equipment [1] - This matter does not constitute a related party transaction and is subject to shareholder meeting approval, with no objections from the sponsor institution [1]